Canandaigua National Bank & Trust CO Biogen Inc. Transaction History

Canandaigua National Bank & Trust CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$217.44 - $243.88 $192,216 - $215,589	-884 Closed	0 $0
Q2 2019 Jul 19, 2019	SELL	$219.29 - $241.72 $3,289 - $3,625	-15 Reduced 1.67%	884 $207,000
Q1 2019 Apr 25, 2019	BUY	$216.71 - $338.96 $22,754 - $35,590	105 Added 13.22%	899 $213,000
Q4 2018 Feb 06, 2019	SELL	$278.5 - $352.75 $2,228 - $2,822	-8 Reduced 1.0%	794 $239,000
Q3 2018 Nov 02, 2018	SELL	$293.51 - $383.83 $84,824 - $110,926	-289 Reduced 26.49%	802 $283,000
Q2 2018 Aug 03, 2018	BUY	$257.52 - $306.91 $21,631 - $25,780	84 Added 8.34%	1,091 $317,000
Q1 2018 May 09, 2018	BUY	$260.13 - $367.91 $261,950 - $370,485	1,007 New	1,007 $276,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Canandaigua National Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Canandaigua National Bank & Trust CO with notifications on news.